Form D · Other
BIOPTIX DIAGNOSTICS, INC.
Boulder, CO · CIK 0001386616
Offering snapshot reported May 13, 2016 · SEC filing
- Reported sold
- $2.46M Offering amount: $4.18M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 13, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,663,300 → $2,463,300
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2016 | Amendment | $2,463,300 | $800,000vs Feb 12, 2016 | 18 | SEC filing |
| Feb 12, 2016 | Amendment | $1,663,300 | $663,300vs Nov 24, 2015 | 18 | SEC filing |
| Nov 24, 2015 | Initial | $1,000,000 | No comparison | 14 | SEC filing |
| Sep 1, 2015 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
| Feb 26, 2015 | Initial | $1,500,000 | No comparison | 2 | SEC filing |
| Aug 13, 2014 | Initial | $2,054,210 | No comparison | 18 | SEC filing |
| Jul 10, 2013 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Mar 13, 2013 | Initial | $6,228,202 | No comparison | 25 | SEC filing |
| Oct 17, 2011 | Initial | $44,999 | No comparison | 1 | SEC filing |
| Mar 17, 2011 | Initial | $4,464,044 | No comparison | 26 | SEC filing |
| Aug 26, 2010 | Initial | $1,196,599 | No comparison | 12 | SEC filing |
| Jul 14, 2010 | Initial | $10,000 | No comparison | 1 | SEC filing |
| Dec 18, 2009 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jul 13, 2009 | Amendment | $3,412,372 | $344,414vs Mar 23, 2009 | 14 | SEC filing |
| Mar 23, 2009 | Initial | $3,067,958 | No comparison | Not reported | SEC filing |
| Sep 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 10, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-251865
Source: Form D, filed May 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dmitry Akhanov | Director |
| William Coleman | Director |
| John Creecy | Director |
| Evgeny Evdokimov | Director |
| J. William Freytag | Director |
| Kyle Lefkoff | Director |
| Ron Lowy | Director |
| William Marshall | Director |
| Mikhail Plam | Director |
| Michael Routh | Director |
| Konstantin Severinov | Director |
| Nolan Smith | Executive |
| Richard Whitcomb | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
1775 38 Th Street
Boulder, CO, 80301
Boulder, CO, 80301